All In Biotech

Drug Trial Radar · NCT07752394

Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma

Efficacy and Safety of Penpulimab Combined With Chemotherapy as Neoadjuvant Therapy in Patients With Locally Advanced Hypopharyngeal Carcinoma

Last checked: Nov 19, 2026Latest source record: Aug 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Aug 23, 2026

Primary completion

Aug 23, 2031

Study completion Aug 23, 2031

Sponsor

Lead sponsor
Tang-Du HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 7, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, single-arm, phase II clinical study aimed to evaluate the efficacy and safety of penpulimab combined with chemotherapy in the treatment of locally advanced hypopharyngeal carcinoma.

Conditions

  • Head & Neck Cancer

Interventions

  • FinotonlimabDrug

    Finotonlimab was administered by intravenous infusion at a dose of 200 mg,d1, Q3W,for 2-4 cycles Other Name:

  • Nab-paclitaxelDrug

    treatment Regimen:Nab-paclitaxel was administered by intravenous infusion at a dose of 260mg/m² ,d1, Q3W,for 2-4 cycles

  • carboplatinDrug

    treatment Regimen: Carboplatin dosage was calculated using the Calvert formula (dose = target AUC × \[GFR + 25\]), d1,IV,Q3W,for 2-4 cycles

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Major pathological response rate (MPR)Time frame: [Time Frame: Within 1-2 week after radical surgery (performed 2-3 weeks after the completion of 2 cycles of neoadjuvant treatment)]

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tangdu Hospital, Air Force Medical University, Xi'an 710038, Shaanxi Province, China

    Xi’an, Shanxi, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.